期刊文献+

阴离子交换HPLC法精确测定肝素钠中的多硫酸软骨素和硫酸皮肤素 被引量:1

Simultaneous determination of over-sulfated chondroitin sulfate and dermatan sulfate in heparin sodium by anion exchange HPLC
原文传递
导出
摘要 目的:建立可同时测定肝素钠中的多硫酸软骨素(OSCS)和硫酸皮肤素(DS)等杂质的有关物质检测方法。方法:应用高效液相色谱-紫外可见光检测器,2种阴离子交换树脂为填充剂的色谱柱,在pH 3.0的酸性体系下,设计了5种由不同流动相体系、洗脱梯度和不同阴离子交换柱组成的分析方法,比较了其分离度。结果:5种方法中以方法 E灵敏度最高,理论塔板数和分离度也最高,多硫酸软骨素的检测限和定量限分别为0.025%和0.03%;硫酸皮肤素的检测限和定量限分别为0.03%和0.05%;多硫酸软骨素和硫酸皮肤素的加标回收率分别为102.5%和96.0%。结论:采用方法 E的弱阴离子交换HPLC法与现有药典标准方法相比,具有更好的灵敏度和准确度。 Objective: To establish a precise method to simultaneously determine the related substances of over-sulfated chondroitin sulfate(OSCS)and dermatan sulfate(DS)in heparin products(HP).Methods: VWD was applied,and the separation was performed on two kinds of anion exchanger columns:Dionex IonPac AS11(250 mm×2 mm,13 μm)and TSK-GEL DEAE-5PW(75 mm×2 mm,10 μm)with three groups of mobile phase at pH 3.0.Five methods were established based on the above columns,mobile phases and gradients,and their resolution of over-sulfated chondroitin sulfate and dermatan sulfate were compared.Results: Method E was the optimized method with the greatest resolution and theoretical plates,the limit of detection(LOD)and limit of quantitation(LOQ)for the over-sulfated chondroitin sulfate in heparin sodium were 0.025% and 0.03%,respectively.The LOD and LOQ for dermatan sulfate were 0.03% and 0.05%,respectively.The average recoveries of over-sulfated chondroitin sulfate and dermatan sulfate were 102.5% and 96.0%,respectively.Conclusion: This method is more accurate,sensitive,robust and reproducible compared with the existing pharmacopoeia method of heparin sodium products.
出处 《药物分析杂志》 CAS CSCD 北大核心 2013年第4期642-647,共6页 Chinese Journal of Pharmaceutical Analysis
关键词 阴离子交换 肝素钠 多硫酸软骨素 硫酸皮肤素 高效液相色谱 anion exchange heparin sodium over-sulfated chondroitin sulfate(OSCS) dermatan sulfate(DS) HPLC
  • 相关文献

参考文献12

  • 1高照明,张玉冰,于永良.核磁共振内标法定量分析肝素钠中多硫酸软骨素[J].分析化学,2011,39(4):601-602. 被引量:13
  • 2Kihimoto TK, Viswanathan K, Ganguly T, et al. Contaminated hepa- rin associated with adverse clinical events and activation of the con- tact system. N Engl J Med ,2008 ,358 ( 23 ) : 2457.
  • 3Zhang ZQ, Boyangzi L, Jiraporn S, et al. Analysis of pharmaceutical heparins and potential contaminants usingI H - NMR and PAGE. J Pharm Sci ,2009,98 ( 11 ) :4017.
  • 4JISheng-li(姬胜利),CUIHui-fei(崔慧斐),CHIYan-qing(迟延青),etal.一种多硫酸化硫酸软骨素及其制备方法.CN:200510045393.9,2006-06-21.
  • 5Pan J, Qian Y, Zhou X, et al. Identification of chemically sulfated/ desulfated glycosaminoglycans in contaminated heparins and devel- opment of a simple assay for the detection of most contaminants in heparin. Glycobiol Insights,201 O, 2010 ( 2 ) : 1.
  • 6Beni S, Limtiaco JF, Larive CK. Analysis and characterization of hep- arin impurities. Anal Bioanal Chem,2011,399 ( 2 ) : 527 EP 6.4. 2008. 638.
  • 7Trehy ML, Reepmeyer JC, Kolinski RE, et al. Analysis of heparin so- dium by SAX/HPLC for contaminants and impurities. J Pharm Bi- omed Anal,2009,49 ( 3 ) : 670.
  • 8Thermo Fisher Scientific Inc. Determination of over - sulfated chon- droitin sulfate and dermatan sulfate in heparin sodium using anion - exchange chromatography with uv detection. [ EB/OL]. 2010. [ 2012 - 05 - 11 ]. http://www, dionex, com/en - us/webdocs/78398 - AN235 - IonPac - Heparin - 12Nov2010 - LPN2306 -03. pdf.
  • 9Heparin Sodium. Pharmacopeial Forum,2009,35 (5) : 1085.
  • 10Hashii N, Kawasaki N, Itoh S, et al. Heparin identification test and purity test for OSCS in heparin sodium and heparin calcium by weak anion - exchange high - performance liquid chromatography. Biologi- cals,2010,38(5) :539.

二级参考文献10

  • 1孙伟,丁雅勤,韩军英,焦奎,怀盈盈.结晶紫线性扫描伏安法测定肝素钠的研究[J].药物分析杂志,2005,25(12):1495-1498. 被引量:8
  • 2ChP(中国药典).2010.Vol Ⅱ(二部):Appendix(附录).
  • 3The supplement method of Heparin Sodium impurities test method employing CE(毛细管电泳分析肝素钠杂质的补充检验方法).国家药品监督管理局颁布药品补充检验方法和检验项目批准件.2008.
  • 4Zhang ZQ,Boyangzi Li,Jiraporn Suwan,et al.Analysis of pharmaceutical heparins and potential contaminants using 1H-NMR and PAGE.J Pharm Sci,2009,98(11):4017.
  • 5U.S. Food and Drug Administration, Center for Drug Evaluation and Research Site on Adverseevents Associated with Heparin, httpJ/www, fda. gov/cder/drug/ infopage/ heparin/default, htm, 2008.
  • 6WANGHao YUGuang-Li ZHAOXia HAOCui HUYan-Nan YINXiu-Hong(王皓 于广利 赵峡 郝翠 胡艳南 殷秀红).分析化学,:1147-1151.
  • 7McEwen I, Mulloy B, Hellwig E. Pharmeuropa Bio. , 2008 Dee, 2008(1): 31-39.
  • 8Liu H Y, Zhang Z Q, Linhardt R J. Natural Product Reports, 2009, 26, (3): 313-321.
  • 9ZHAOXia LIGuang-Sheng YUGuang-Li WANGJin-Xia WANGHao SUNShu-Meng ZHENGChen(赵峡 李广生 于广利 王金霞 王皓 孙淑萌 郑晨).高等化学化学学报,:479-483.
  • 10邓锋,梁蔚阳.毛细管电泳法检测肝素钠注射液中过硫酸软骨素结果的讨论[J].今日药学,2009,19(10):28-29. 被引量:1

共引文献49

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部